LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 42.45 | 17.25 | 4 | 3504 | 0.0011 | -0.1736 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 42.45 | 17.25 | 3045 | 3504 | 0.8690 | 0.9637 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 42.45 | 17.25 | 5 | 3504 | 0.0014 | -0.1492 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 42.45 | 17.25 | 3235 | 3504 | 0.9232 | 0.9793 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 44.42 | 17.25 | 5 | 3895 | 0.0013 | -0.1465 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 44.42 | 17.25 | 3405 | 3895 | 0.8740 | 0.9659 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 44.42 | 17.25 | 8 | 3895 | 0.0021 | -0.0936 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 44.42 | 17.25 | 3542 | 3895 | 0.9092 | 0.9758 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 46.39 | 17.25 | 7 | 4141 | 0.0017 | -0.1078 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 46.39 | 17.25 | 3700 | 4141 | 0.8934 | 0.9717 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 46.39 | 17.25 | 9 | 4141 | 0.0022 | -0.0790 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 46.39 | 17.25 | 3806 | 4141 | 0.9190 | 0.9787 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 48.36 | 17.25 | 7 | 4390 | 0.0016 | -0.1067 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 48.36 | 17.25 | 3942 | 4390 | 0.8979 | 0.9732 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 48.36 | 17.25 | 10 | 4390 | 0.0023 | -0.0660 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 48.36 | 17.25 | 4203 | 4390 | 0.9573 | 0.9891 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 50.33 | 17.25 | 7 | 4651 | 0.0015 | -0.1057 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 50.33 | 17.25 | 4269 | 4651 | 0.9178 | 0.9789 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 50.33 | 17.25 | 10 | 4651 | 0.0022 | -0.0653 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 50.33 | 17.25 | 4556 | 4651 | 0.9795 | 0.9949 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 52.30 | 17.25 | 4 | 4798 | 0.0008 | -0.1647 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 52.30 | 17.25 | 4553 | 4798 | 0.9488 | 0.9871 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 52.30 | 17.25 | 13 | 4798 | 0.0027 | -0.0342 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 52.30 | 17.25 | 4928 | 4798 | 1.0270 | 1.0066 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 54.27 | 17.25 | 15 | 4884 | 0.0031 | -0.0170 | MN20160310_N02 | C19 |